Examkin

Question

Difficulty: Very hardPreventive Care and Screening

Match each of the following complex ambulatory patient profiles with the single most appropriate, evidence-based preventive screening or immunization recommendation.

  • A 61-year-old woman with chronic congestive heart failure and diabetes mellitus. She received a 20-valent pneumococcal conjugate vaccine (PCV20) at age 60.Administration of a single dose of respiratory syncytial virus (RSV) vaccine
  • A 24-year-old woman who is newly diagnosed with HIV (CD4 count 550 cells/mm³). Her last cervical cytology test was normal at age 21.Cervical cytology testing now and repeated annually for three consecutive years
  • A 35-year-old man with recently diagnosed severe rheumatoid arthritis. He had chickenpox in childhood and is scheduled to begin immunosuppressive therapy with rituximab next month.Administration of the recombinant zoster vaccine (RZV) series
  • A 72-year-old man with end-stage, oxygen-dependent COPD who is bedbound. He has a 50 pack-year smoking history and quit 2 years ago.Discontinuation of annual low-dose computed tomography (LDCT) lung cancer screening

Answer

The 61-year-old with heart failure receives the RSV vaccine; the newly diagnosed 24-year-old with HIV undergoes annual cervical cytology; the 35-year-old starting immunosuppression receives the RZV series; and the 72-year-old with end-stage COPD discontinues LDCT screening.
Each patient requires a highly specific deviation from average-risk screening and immunization pathways. The RSV vaccine targets adults 60-74 with high-risk cardiopulmonary conditions. HIV infection mandates an accelerated annual cervical cytology schedule. Targeted immunosuppressive therapy expands the RZV indication to young adults over 19. Finally, end-stage, bedbound conditions necessitate the cessation of cancer screening because the patient is no longer a candidate for curative intent.

Step-by-Step Solution

1
Evaluate the 61-year-old woman with heart failure and diabetes.
Identify her eligibility for the newly updated RSV vaccine guidelines.
ACIP recommends RSV vaccination for all adults 75 and older, and selectively for adults 60-74 with elevated risk conditions like heart failure and diabetes.
2
Evaluate the 24-year-old woman with newly diagnosed HIV.
Identify the need for an intensified cervical cancer screening schedule.
HIV infection represents an immunocompromised state that alters the routine 3-year cytology interval to a strict annual interval for the first three years following diagnosis.
3
Evaluate the 35-year-old man starting rituximab therapy.
Identify the indication for the recombinant zoster vaccine (RZV) in a patient under the age of 50.
RZV is recommended for patients aged 19 and older who are or will become severely immunosuppressed, and it must ideally be administered prior to initiating the immunosuppressive therapy.
4
Evaluate the 72-year-old man with end-stage COPD and a 50 pack-year smoking history.
Determine that lung cancer screening should be immediately discontinued.
USPSTF guidelines definitively state that LDCT should be stopped if a comorbid condition severely limits life expectancy or makes the patient a poor surgical candidate for curative lung resection.

Key Concept

Application of advanced preventive care guidelines, emphasizing nuanced modifications required for specific comorbidities, immunocompromised states, and end-stage life-limiting conditions.
Estimated Time:2m 30s
Rate this question

Topics

Preventive Care and Screening

More questions from this topic